Biodesix, Inc.
Biodesix, Inc. (BDSX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BDSX · as of Jun 9, 2026
Key Statistics
Explore Biodesix, Inc. Data
bdsx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The BDSX analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $8.67, representing -42.01% downside from the current price of $14.95.
Competitors & Peers
bdsx competitorsBDSX
ALGS
INMB
MRSN
NOTV
OKURStock Performance
Full HistoryAbout Biodesix, Inc.
Biodesix, Inc. is a data-driven diagnostic solutions provider operating across the United States. Its primary focus includes a comprehensive suite of blood-based lung tests, marketed as the Nodify Lun…
what is biodesix, inc. · bdsx stock overview · biodesix, inc. company profile · who is biodesix, inc. ceo · bdsx NASDAQ · biodesix, inc. headquarters · biodesix, inc. business segments
About Stock Overview & Key Data
Biodesix, Inc. (BDSX) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Oct 28, 2020. As of the latest trading session, BDSX stock price is $14.95, with a market capitalization of $121.7M. The stock has returned +158.20% over the past 12 months and +119.85% year-to-date.
According to 7 Wall Street analysts, the consensus rating for Biodesix, Inc. stock is Buy, with an average 12-month price target of $8.67. In fiscal year 2025, Biodesix, Inc. reported revenue of $88.5M and net income of -$35.3M. For detailed data — including Biodesix, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Biodesix, Inc. (BDSX) stock price is $14.95. The stock is traded on NASDAQ under the ticker symbol BDSX. The 52-week range is $5.00 – $20.21.